Médecins pour Chimiothérapie pour le cancer de la prostate à l'étranger — Page 2

Professeur d'oncologie médicale avec plus de 20 ans d'expérience, le Dr Cicin est spécialisé dans le traitement du cancer de la prostate à l'Hôpital Liv Topkapı de l'Université İstinye.

• Formation spécialisée (Fellowship) en oncologie médicale à l'Université de Trakya
• Ancien professeur agrégé à la Faculté de médecine de l'Université de Trakya
• Vaste expérience en pratique clinique et en oncologie académique

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Le Prof. Associé Atakan Topcu est spécialisé dans les thérapies ciblées et l'immunothérapie pour le cancer de la prostate à l'hôpital de district Medipol Acibadem.

• A publié plus de 50 articles scientifiques en oncologie
• Membre de la Société Européenne d'Oncologie Médicale (ESMO)
• Expert en oncologie gériatrique et en malnutrition liée au cancer
• Formation de spécialisation (Fellowship) en oncologie médicale à l'Université Bezmialem Vakıf

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Le Dr Shaunak Valame a présenté ses recherches sur le cancer de l'estomac lors du prestigieux Gastrointestinal Cancer Symposium de l'ASCO.

• Formé en oncologie médicale à l'Indraprastha Apollo Hospital
• Spécialisé dans les bases moléculaires du cancer et les thérapies ciblées
• Expérience en tant que chef de clinique en oncologie médicale au Jawaharlal Nehru Cancer Hospital
• A donné des conférences à l'International Winter School of Oncology de l'AIIMS

Plus de 50 000 chirurgies oncologiques réalisées – Le Dr Raj Nagarkar apporte une vaste expérience au traitement du cancer de la prostate au HCG Manavata Cancer Centre.

• Formé au Tata Memorial Hospital et au Royal College of Surgeons
• Impliqué dans plus de 200 essais cliniques pour de nouveaux traitements
• Spécialisation en oncologie chirurgicale mammaire et thoracique
• Professeur pour la surspécialité DNB en oncologie chirurgicale

Le Dr Lalit Banswal réalise des chirurgies minimalement invasives du cancer avec d'excellents résultats – au HCG Manavata Cancer Centre.

• Plus de 10 ans d'expérience en oncologie chirurgicale
• A effectué plus de 10 000 chirurgies majeures
• Formé en cancer gastro-intestinal au Tata Medical Centre
• A publié de multiples articles de recherche nationaux et internationaux
• Reconnu pour son approche éthique et centrée sur le patient

Le Dr Shaikh est spécialisé dans les chirurgies du cancer de la bouche et la réadaptation fonctionnelle au HCG Manavata Cancer Centre.

• 3 ans d'expérience ciblée en oncologie chirurgicale
• Formation par bourse de recherche (Fellowship) en oncologie chirurgicale de la tête et du cou
• Expert en techniques de préservation d'organe
• Compétent dans les chirurgies maxillofaciales majeures
• Chercheur publié dans le domaine

Expert en immunothérapie et thérapie métronomique pour les cancers avancés – Le Dr Kate a été formée au Tata Memorial Hospital, l'un des meilleurs centres de cancérologie d'Inde.

• Spécialiste des cancers du poumon, du sein et génito-urinaires
• Membre de l'ASCO, de l'ESMO et d'autres sociétés d'oncologie de premier plan
• A présenté des recherches sur le cancer du poumon lors de la Conférence mondiale sur le cancer du poumon
• Lauréat du prestigieux prix de voyage de la WCLC en 2018

Le Dr Chaitainya Borde a traité plus de 30 000 TEP et 1 000 patients atteints de cancer de la thyroïde au HCG Manavata Cancer Centre.

• 12 ans d'expérience en médecine nucléaire
• Spécialisé dans les thérapies à l'iode radioactif et au Lu-177 RN
• Maîtrise tous les types de scintigraphies nucléaires et de TEP-TDM
• Articles publiés dans diverses revues médicales

Le Dr Sridhar P.S. est spécialisé en radiothérapie et chimiothérapie pour le cancer de la prostate au HCG Manavata Cancer Centre.

• Plus de 20 ans d'expérience en oncologie radiothérapique
• Diplômé du National Board en radiothérapie
• Membre de l'Association of Radiation Oncology of India
• Actif au sein de la Society for Neuro-Oncology